Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Coherus BioSciences (CHRS) Commences $75M Offering of Common Stock
-
Coherus Announces Proposed Public Offering of Common Stock
-
Maxim Group LLC Expands Equity Research Platform With the Appointment of a Senior TMT Analyst
-
FRONTEO, Inc (FTEO) PT Raised to $23 at Maxim Group
-
Dave & Buster's (PLAY) PT Raised to Street High $68 at Maxim Group
-
Dynagas LNG Partners (DLNG) PT Lowered to $11 at Maxim Group
-
BeiGene, Ltd. (BGNE) PT Raised to $225 at Maxim Group on China PARP Study
-
Cracker Barrel (CBRL) PT Raised to $170 at Maxim Group
-
Milestone Scientific (MLSS) PT Lowered to $3 at Maxim Group
-
UPDATE: Maxim Group Starts Neurotrope (NTRP) at Buy
-
UPDATE: Maxim Group Starts Capricor Therapeutics (CAPR) at Buy
-
UPDATE: Maxim Group Starts VolitionRX (VNRX) at Buy
-
BioHiTech Global, Inc (BHTG) PT Lowered to $7 at Maxim Group
-
Maxim Group Upgrades Red Robin Gourmet Burgers (RRGB) to Buy
-
MoviePass: the unicorn that jumped into Wall Street too soon
-
REEDS, Inc. (REED) PT Raised to $4 at Maxim Group
-
Sophiris Bio (SPHS) PT Raised to $8 at Maxim Group
-
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
-
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
-
Coherus Biosciences (CHRS) PT Raised to $22 at Maxim Group
-
CytoSorbents (CTSO) PT Raised to $13 at Maxim Group
-
First Savings Financial Group (FSFG) PT Raised to $79 at Maxim Group
-
Adamis Pharmaceuticals (ADMP) PT Raised to $10 at Maxim Group
-
Viveve Medical (VIVE) PT Lowered to $9 at Maxim Group
-
The Joint Corp (JYNT) PT Raised to $10 at Maxim Group
-
BioLife Solutions (BLFS) PT Raised to $12 at Maxim Group
-
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
-
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
-
Hain Celestial (HAIN) PT Lowered to $40 at Maxim Group
-
iPass Inc. (IPAS) PT Lowered to $1.25 at Maxim Group
-
Potbelly Corp (PBPB) PT Raised to $13 at Maxim Group
-
Ellington (EFC) PT Raised to $19.50 at Maxim Group
-
PAVmed Sets Record Date for Previously Announced Rights Offering
-
Atossa Genetics Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Maxim Group Downgrades American Capital Mortgage (MTGE) to Hold
-
Maxim Group Downgrades Arlington Asset Investment (AI) to Hold
-
Whitestone REIT Mails Letter to Shareholders
-
Coherus Biosciences (CHRS) PT Raised to $18 at Maxim Group as Neulasta BLA Re-Submitted
-
Tableau Software (DATA) PT Raised to $102 at Maxim Group
-
UPDATE: Maxim Group Upgrades Onconova Therapeutics (ONTX) to Buy
-
Apple (AAPL) PT Lowered to $204 at Maxim Group
-
Brinker Int'l (EAT) PT Raised to $55 at Maxim Group
-
Gilead Sciences (GILD) PT Lowered to $89 at Maxim Group
-
Maxim Group Downgrades Intevac (IVAC) to Hold
-
Elevate Credit Inc (ELVT) PT Raised to $10 at Maxim Group
-
RumbleOn, Inc. (RMBL) PT Raised to $8 at Maxim Group
-
Sterling Bancorp (STL) PT Raised to $36 at Maxim Group
-
Maxim Group Downgrades Texas Roadhouse (TXRH) to Hold
-
Coffee Holding Co. (JVA) PT Raised to $9 at Maxim Group
-
Maxim Group LLC Expands Equity Research Platform With the Appointment of a Senior Biotechnology Analyst

